Table 1 Patient Characteristics and Events (Major and Minor Bleeding & All-type Thromboembolic Events). Data shown for both the IDPTP Cohort and for thepatients that were excluded

Patients

19

82

 Age (years)

71 (r41)

67 (r51)

 Male

11 (58%)

43 (52%)

 Metastatic

10 (53%)

56 (68%)

 WHO PS 0–1

10 (53%)

67 (82%)

Chemotherapy

^a14 (73%)

^b82 (100%)

 FOLFIRINOX

2 (10%)

18 (22%)

 Gemcitabine SA

10 (52%)

48 (58%)

 Gem-Based Combi

1 (5%)

16 (20%)

 No Chemo

5 (27%)

–

Events (Bleeding)

4 (20%)

12 (14.5%)

 #Major Bleeding

2 (10%)

10 (12.2%)

 Upper GI bleed

2 (100%)

7 (70%)

 Lower GI bleed

–

2 (20%)

 Genitourinary

1 (10%)

 #Minor Bleeding

2 (10%)

^c2 (2.5%)

Events (AT-TE)

7 (37%)

7 (8.5%)

 DVT

2

2

 i-PE

2

2

 PE

–

1

 i-PE & DVT

–

1

 CVA

2

1

 DVT & Visceral

1